Senthooran Selvarajah
Development and validation of protein microarray technology for simultaneous inflammatory mediator detection in human sera
Selvarajah, Senthooran; Negm, Ola H.; Hamed, Mohamed R.; Tubby, Carolyn; Todd, Ian; Tighe, Patrick J.; Harrison, Tim; Fairclough, Lucy C.
Authors
Dr Ola Negm ola.negm@nottingham.ac.uk
ASSISTANT PROFESSOR
Mohamed R. Hamed
Carolyn Tubby
Ian Todd
Professor PATRICK TIGHE paddy.tighe@nottingham.ac.uk
PROFESSOR OF MOLECULAR IMMUNOLOGY
Professor TIM HARRISON tim.harrison@nottingham.ac.uk
PROFESSOR OF ASTHMA AND RESPIRATORY MEDICINE
Professor Lucy Fairclough LUCY.FAIRCLOUGH@NOTTINGHAM.AC.UK
PROFESSOR OF IMMUNOLOGY
Abstract
© 2014 Senthooran Selvarajah et al. Biomarkers, including cytokines, can help in the diagnosis, prognosis, and prediction of treatment response across a wide range of disease settings. Consequently, the recent emergence of protein microarray technology, which is able to quantify a range of inflammatory mediators in a large number of samples simultaneously, has become highly desirable. However, the cost of commercial systems remains somewhat prohibitive. Here we show the development, validation, and implementation of an in-house microarray platform which enables the simultaneous quantitative analysis of multiple protein biomarkers. The accuracy and precision of the in-house microarray system were investigated according to the Food and Drug Administration (FDA) guidelines for pharmacokinetic assay validation. The assay fell within these limits for all but the very low-abundant cytokines, such as interleukin- (IL-) 10. Additionally, there were no significant differences between cytokine detection using our microarray system and the "gold standard" ELISA format. Crucially, future biomarker detection need not be limited to the 16 cytokines shown here but could be expanded as required. In conclusion, we detail a bespoke protein microarray system, utilizing well-validated ELISA reagents, that allows accurate, precise, and reproducible multiplexed biomarker quantification, comparable with commercial ELISA, and allowing customization beyond that of similar commercial microarrays.
Citation
Selvarajah, S., Negm, O. H., Hamed, M. R., Tubby, C., Todd, I., Tighe, P. J., Harrison, T., & Fairclough, L. C. (2014). Development and validation of protein microarray technology for simultaneous inflammatory mediator detection in human sera. Mediators of Inflammation, 2014, 1-12. https://doi.org/10.1155/2014/820304
Journal Article Type | Article |
---|---|
Acceptance Date | Sep 8, 2014 |
Publication Date | Oct 14, 2014 |
Deposit Date | Feb 23, 2017 |
Publicly Available Date | Feb 23, 2017 |
Journal | Mediators of Inflammation |
Print ISSN | 0962-9351 |
Electronic ISSN | 1466-1861 |
Publisher | Hindawi |
Peer Reviewed | Peer Reviewed |
Volume | 2014 |
Article Number | 820304 |
Pages | 1-12 |
DOI | https://doi.org/10.1155/2014/820304 |
Public URL | https://nottingham-repository.worktribe.com/output/738310 |
Publisher URL | https://www.hindawi.com/journals/mi/2014/820304/ |
Contract Date | Feb 23, 2017 |
Files
Selvarajah et al 2014.pdf
(3.2 Mb)
PDF
Copyright Statement
Copyright information regarding this work can be found at the following address: http://creativecommons.org/licenses/by/4.0
You might also like
The Role of Extracellular Vesicles in Allergic Sensitization: A Systematic Review
(2024)
Journal Article
The Role of Extracellular Vesicles in Atopic Dermatitis
(2024)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search